In a recent episode of our “Molecular Imaging in Focus” series, Surekha Yadav, MBBS, MD, discussed research presented at the SNMMI conference that showed significant advantages of PSMA PET over conventional imaging for detection of osseous oligometastatic prostate cancer (PCa).
The VascularAssist Occlusion Triage software reportedly demonstrated over a 90 percent sensitivity for detecting peripheral artery disease (PAD) on CT in clinical performance testing.
A combination of incentives and embrace of technology-enhanced efficiencies may facilitate underlying ‘autopilot’ motivations toward increased achievement in navigating radiology worklists.
Catch up on the top radiology content of the past week.
The use of FAPI PET/CT offered a 97 percent pooled sensitivity for detecting peritoneal metastases in a patient-based analysis in a new meta-analysis involving over 800 patients.
New research suggests that photon-counting CT may provide critical insight into a diagnostic dilemma that has challenged radiologists for decades.
For patients with advanced melanoma, the melanin-targeted PET radiotracer (¹⁸F)DMPY2 offered superior detection of metastatic foci in the brain and liver in comparison to (¹⁸F)FDG, according to preliminary comparative research presented at the recent SNMMI conference.
In a recent interview, Mary L. Bouxsein, PhD, discussed challenges with access to dual-energy X-ray absorptiometry (DEXA) screening for osteoporosis, the emergence of biomechanical CT (BCT) and the potential impact of national Medicare coverage of BCT for bone mass measurement.
Catch up on the latest imaging research from the recent SNMMI conference.
For pancreatic cancers less than or equal to 20 mm, a deep learning model offered a nearly 45 percent higher sensitivity rate with non-contrast CT in comparison to unassisted radiologist interpretation.
Noting that frustration over slow implementation of technological advances may be contributing to mounting radiologist frustration and subsequent burnout, this author offers key principles for integrating technological solutions into radiology workflows.
In the latest episode of the Molecular Imaging in Focus series, Michael Hofman, MBBS, FRACP, discussed the potential of an emerging PET radiotracer for DVT detection spotlighted in SNMMI’s “Image of the Year,” a new advance in total body PET/CT and other highlights from the SNMMI conference.
While use of an AI software demonstrated significantly higher accuracy in evaluating BI-RADS 2 presentations and no significant difference with radiologists in BI-RADS 4 assessments of breast ultrasound in a sub-analysis, researchers noted the exclusion of galactoceles, fluid collections and skin lesions that are commonly found in pregnant and lactating women.
In a recent interview, new SNMMI president Heather Jacene, MD, discussed key goals for bolstering workforce development in nuclear medicine, improving infrastructure equity and optimizing emerging advances to facilitate precision treatments in oncology.
While perspective is important for reining in an unrelenting perfectionism here and there, the inner drive for achievement can serve as fuel for consistently high quality over the course of a radiologist’s career.
Indicated for the detection and visualization of abnormal vascularity in the central nervous system (CNS) and non-CNS body regions, gadoquatrane provides 60 percent less gadolinium dosing in comparison to other macrocyclic gadolinium (Gd)-based contrast agents (mGBCAs).
Catch up on the top radiology content of the past week.
In a recent interview, Nina Kottler, MD, discussed the challenges with traditional radiology reporting, its impact on cognitive load and the recently launched AI-enabled platform Mosaic Reporting.
New research suggests the silent accumulated social costs of remote work are outweighing the benefits of increased flexibility and autonomy.
In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, discusses new research findings from a study involving over 111,000 women that suggest the potential utility of GLP-1 receptor agonists for reducing breast cancer risk.
For men with high clinical risk for prostate cancer (PCa) and a lack of significant findings on mpMRI, triage use of PSMA PET/CT resulted in a 49 percent reduction of biopsies and an 18 percent reduction in detection of clinically insignificant PCa, according to newly published research.
The AI-enabled image processing with SubtleHD(CT) software reportedly facilitates improved noise reduction and image quality for computed tomography (CT) exams.
The Reporting Pro software reportedly offers an array of AI-enabled features that may help streamline radiology reports.
In a new survey of over 2,000 health-care professionals on AI use, respondents cited benefits ranging from improved work-life balance to preventing medical errors as well as concerns about overreliance on AI and inconsistent or limited training.
In recent interviews, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, noted a lack of point-of-care safety requirements for MRI, a lack of state oversight, and a prevailing lack of minimum standards overall for MRI safety.
What radiology leaders need to know about the 2026 Medicare Physician Fee Schedule.
David Gruen, MD, MBA, FACR, of Advanced Radiology Consultants, shares how leading programs turned clinical evidence into operational reality.
What's already being done with large language models in radiology practice today.
Preoperative use of (68Ga)Ga-FAPI-46 PET/CT demonstrated an 81 percent intraclass correlation coefficient (ICC) with the intraoperative peritoneal cancer index (PCI) in comparison to 76 percent for MRI and 54 percent for (18F)FDG PET/CT (FDG PET), according to new research presented at the SNMMI conference.
The proportion of breast cancer potentially flagged by three different AI algorithms 10 years prior to diagnosis ranged between 12.7 to 17 percent, according to newly published retrospective research.
